This year’s Genetics Virtual Week features valued customers and experts in the areas of rare disease genomics, molecular diagnostics, and precision medicine. Below are some compelling discussions that you won’t want to miss. Can't make the live event? Register and get access to the recordings.
ANN ARBOR, MICH. (PRWEB) FEBRUARY 22, 2022
Genomenon, Inc. recently announced a partnership with Don’t Forget Morgan, a nonprofit support organization focused on rare disease patients living with Beta-Propeller Protein-Associated Neurodegeneration (BPAN), a progressive disease causing abnormal iron deposits in the brain leading to profound developmental delays. The goal of this collaboration is to provide resources to assist researchers and encourage pharmaceutical companies to invest in finding effective treatments for BPAN, as well as empower patient care teams with actionable genetic information.
ANN ARBOR, MICH. (PRWEB) JANUARY 20, 2022
Following a year of 125% revenue growth, Genomenon®, Inc., an AI-driven genomics company, Thursday announced that Sean Kearney has been appointed Chief Financial Officer (CFO), effective immediately. As a valuable member of Genomenon's executive leadership team, Mr. Kearney will lead the company’s financial operations.
Your opinions are needed!
As we collectively navigate our way to the end of 2021 and face 2022, Michigan is venturing new paths of work, challenges of supply chains, and the continuing evolution of the talent issue! As a leading voice for small businesses in Michigan, the Michigan Business Network (MBN) believes the people making critical decisions need to hear how your business is doing as we emerge from the COVID-19 pandemic. That is why MBN, in partnership with Cinnaire, and the generous underwriting support of Michigan Economic Development Corporation are requesting your participation in this edition of the Michigan Future Business Index (MFBI).
